Long-term health-care utilisation in older patients with cancer and the association with the Geriatric 8 screening tool: a retrospective analysis using linked clinical and population-based data in Belgium.
Humans; Aged; Retrospective Studies; Belgium/epidemiology; Patient Acceptance of Health Care; Early Detection of Cancer; Neoplasms/diagnosis; Neoplasms/epidemiology; Neoplasms/therapy; Belgium; Neoplasms; Health (social science); Geriatrics and Gerontology; Psychiatry and Mental Health; Family Practice
Abstract :
[en] [en] BACKGROUND: Little evidence is available on the long-term health-care utilisation of older patients with cancer and whether this is associated with geriatric screening results. We aimed to evaluate long-term health-care utilisation among older patients after cancer diagnosis and the association with baseline Geriatric 8 (G8) screening results.
METHODS: For this retrospective analysis, we included data from three cohort studies for patients (aged ≥70 years) with a new cancer diagnosis who underwent G8 screening between Oct 19, 2009 and Feb 27, 2015, and who survived more than 3 months after G8 screening. The clinical data were linked to cancer registry and health-care reimbursement data for long-term follow-up. The occurrence of outcomes (inpatient hospital admissions, emergency department visits, use of intensive care, contacts with general practitioner [GP], contacts with a specialist, use of home care, and nursing home admissions) was assessed in the 3 years after G8 screening. We assessed the association between outcomes and baseline G8 score (normal score [>14] or abnormal [≤14]) using adjusted rate ratios (aRRs) calculated from Poisson regression and using cumulative incidence calculated as a time-to-event analysis with the Kaplan-Meier method.
FINDINGS: 7556 patients had a new cancer diagnosis, of whom 6391 patients (median age 77 years [IQR 74-82]) met inclusion criteria and were included. 4110 (64·3%) of 6391 patients had an abnormal baseline G8 score (≤14 of 17 points). In the first 3 months after G8 screening, health-care utilisation peaked and then decreased over time, with the exception of GP contacts and home care days, which remained high throughout the 3-year follow-up period. Compared with patients with a normal baseline G8 score, patients with an abnormal baseline G8 score had more hospital admissions (aRR 1·20 [95% CI 1·15-1·25]; p<0·0001), hospital days (1·66 [1·64-1·68]; p<0·0001), emergency department visits (1·42 [1·34-1·52]; p<0·0001), intensive care days (1·49 [1·39-1·60]; p<0·0001), general practitioner contacts (1·19 [1·17-1·20]; p<0·0001), home care days (1·59 [1·58-1·60]; p<0·0001), and nursing home admissions (16·7% vs 3·1%; p<0·0001) in the 3-year follow-up period. At 3 years, of the 2281 patients with a normal baseline G8 score, 1421 (62·3%) continued to live at home independently and 503 (22·0%) had died. Of the 4110 patients with an abnormal baseline G8 score, 1057 (25·7%) continued to live at home independently and 2191 (53·3%) had died.
INTERPRETATION: An abnormal G8 score at cancer diagnosis was associated with increased health-care utilisation in the subsequent 3 years among patients who survived longer than 3 months.
FUNDING: Stand up to Cancer, the Flemish Cancer Society.
Disciplines :
Oncology
Author, co-author :
Depoorter, Victoria; Department of Oncology, KU Leuven, Leuven, Belgium
Vanschoenbeek, Katrijn; Research Department, Belgian Cancer Registry, Brussels, Belgium
Decoster, Lore; Department of Medical Oncology, Vrije Universiteit Brussel, University Hospitals Brussels, Brussels, Belgium
Silversmit, Geert; Research Department, Belgian Cancer Registry, Brussels, Belgium
Debruyne, Philip R; Division of Medical Oncology, Kortrijk Cancer Centre, AZ Groeninge, Kortrijk, Belgium, Medical Technology Research Centre, School of Life Sciences, Anglia Ruskin University, Cambridge, UK, School of Nursing and Midwifery, University of Plymouth, Plymouth, UK
De Groof, Inge; Department of Geriatric Medicine, Iridium Network Antwerp, Sint-Augustinus Cancer Center, Wilrijk, Belgium
Bron, Dominique; Department of Hematology, Institute Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Cornélis, Frank; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Luce, Sylvie; Department of Medical Oncology, University Hospital Erasme, Université Libre de Bruxelles, Brussels, Belgium
Focan, Christian; Department of Oncology, Clinique CHC MontLégia, Liège, Belgium
Verschaeve, Vincent; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium
Debugne, Gwenaëlle; Department of Geriatric Medicine, Centre Hospitalier de Mouscron, Mouscron, Belgium
Langenaeken, Christine; Department of Medical Oncology, AZ Klina Brasschaat, Brasschaat, Belgium
Van Den Bulck, Heidi; Department of Medical Oncology, Imelda Hospital, Bonheiden, Belgium
Goeminne, Jean-Charles; Department of Medical Oncology, Centre Hospitalier Universitaire UCL-Namur, Namur, Belgium
Teurfs, Wesley; Department of Medical Oncology, ZNA Stuivenberg, Antwerp, Belgium
Jerusalem, Guy ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale
Schrijvers, Dirk; Department of Medical Oncology, ZNA Middelheim, Antwerp, Belgium
Petit, Bénédicte; Department of Medical Oncology, Centre Hospitalier Jolimont, La Louvière, Belgium
Rasschaert, Marika; Department of Medical Oncology, University Hospital Antwerp, Edegem, Belgium
Praet, Jean-Philippe; Department of Geriatric Medicine, Centre Hospitalier Universitaire St-Pierre, Free Universities Brussels, Brussels, Belgium
Vandenborre, Katherine; Department of Medical Oncology, AZ Vesalius, Tongeren, Belgium
Milisen, Koen; Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven, Leuven, Belgium, Department of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium
Flamaing, Johan; Department of Public Health and Primary Care, Gerontology and Geriatrics, KU Leuven, Leuven, Belgium, Department of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium
Kenis, Cindy; Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven, Leuven, Belgium, Department of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium, Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium
Verdoodt, Freija; Research Department, Belgian Cancer Registry, Brussels, Belgium
Wildiers, Hans; Department of Oncology, KU Leuven, Leuven, Belgium, Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. Electronic address: hans.wildiers@uzleuven.be
Long-term health-care utilisation in older patients with cancer and the association with the Geriatric 8 screening tool: a retrospective analysis using linked clinical and population-based data in Belgium.
Publication date :
July 2023
Journal title :
The Lancet Healthy Longevity
eISSN :
2666-7568
Publisher :
Elsevier Ltd, England
Volume :
4
Issue :
7
Pages :
e326 - e336
Peer reviewed :
Peer Reviewed verified by ORBi
Funding text :
The study was funded by a grant from Kom op tegen Kanker (Stand up to Cancer, the Flemish Cancer Society). HW is a recipient of a grant of the Fonds Voor Wetenschappelijk Onderzoek Vlaanderen (1802211N). We thank all the physicians who were involved in this study, particularly Katrien Geboers, who was responsible for data collection in her institution, and Harlinde De Schutter for her contribution in the study design and start-up. We thank all patients and healthcare professionals in the collaborating centers that contributed to this study.
Pilleron, S, Sarfati, D, Janssen-Heijnen, M, et al. Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer 144 (2019), 49–58.
Kadambi, S, Loh, KP, Dunne, R, et al. Older adults with cancer and their caregivers—current landscape and future directions for clinical care. Nat Rev Clin Oncol 17 (2020), 742–755.
Jones, D, Di Martino, E, Bradley, SH, et al. Factors affecting the decision to investigate older adults with potential cancer symptoms: a systematic review. Br J Gen Pract 72 (2021), e1–10.
Decoster, L, Kenis, C, Van Puyvelde, K, et al. The influence of clinical assessment (including age) and geriatric assessment on treatment decisions in older patients with cancer. J Geriatr Oncol 4 (2013), 235–241.
Ness, KK, Wogksch, MD, Frailty and aging in cancer survivors. Transl Res 221 (2020), 65–82.
Hoogendijk, EO, Afilalo, J, Ensrud, KE, Kowal, P, Onder, G, Fried, LP, Frailty: implications for clinical practice and public health. Lancet 394 (2019), 1365–1375.
Wildiers, H, Heeren, P, Puts, M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32 (2014), 2595–2603.
Mohile, SG, Dale, W, Somerfield, MR, Hurria, A, Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology summary. J Oncol Pract 14 (2018), 442–446.
Bellera, CA, Rainfray, M, Mathoulin-Pélissier, S, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 23 (2012), 2166–2172.
Garcia, MV, Agar, MR, Soo, WK, To, T, Phillips, JL, Screening tools for identifying older adults with cancer who may benefit from a geriatric assessment: a systematic review. JAMA Oncol 7 (2021), 616–627.
Uranga, C, Chien, LC, Liposits, G, Geriatric screening in older adults with cancer-a Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative. J Geriatr Oncol 13 (2022), 374–377.
van Walree, IC, Scheepers, E, van Huis-Tanja, L, et al. A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer. J Geriatr Oncol 10 (2019), 847–858.
Mazzali, C, Duca, P, Use of administrative data in healthcare research. Intern Emerg Med 10 (2015), 517–524.
Nightingale, G, Battisti, NML, Loh, KP, et al. Perspectives on functional status in older adults with cancer: an interprofessional report from the International Society of Geriatric Oncology (SIOG) nursing and allied health interest group and young SIOG. J Geriatr Oncol 12 (2021), 658–665.
Shrestha, A, Martin, C, Burton, M, Walters, S, Collins, K, Wyld, L, Quality of life versus length of life considerations in cancer patients: a systematic literature review. Psychooncology 28 (2019), 1367–1380.
Kenis, C, Bron, D, Libert, Y, et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol 24 (2013), 1306–1312.
Baitar, A, Kenis, C, Moor, R, et al. Implementation of geriatric assessment-based recommendations in older patients with cancer: a multicentre prospective study. J Geriatr Oncol 6 (2015), 401–410.
Kenis, C, Decoster, L, Flamaing, J, et al. Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium. Ann Oncol 29 (2018), 1987–1994.
Depoorter, V, Vanschoenbeek, K, Decoster, L, et al. Linking clinical and population-based data in older patients with cancer in Belgium: feasibility and clinical outcomes. J Geriatr Oncol, 14, 2023, 101428.
Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
Oken, MM, Creech, RH, Tormey, DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982), 649–655.
Sahai, H, Khurshid, A, Confidence intervals for the mean of a Poisson distribution: a review. Biom J 35 (1993), 857–867.
Lodewijckx, E, Kenis, C, Flamaing, J, et al. Unplanned hospitalizations in older patients with cancer: occurrence and predictive factors. J Geriatr Oncol 12 (2021), 368–374.
Kenis, C, Baitar, A, Decoster, L, et al. The added value of geriatric screening and assessment for predicting overall survival in older patients with cancer. Cancer 124 (2018), 3753–3763.
Otto, E, Culakova, E, Meng, S, et al. Overview of Sankey flow diagrams: focusing on symptom trajectories in older adults with advanced cancer. J Geriatr Oncol 13 (2022), 742–746.
Williams, GR, Dunham, L, Chang, Y, et al. Geriatric assessment predicts hospitalization frequency and long-term care use in older adult cancer survivors. J Oncol Pract 15 (2019), e399–e409.
Hanchate, AD, Clough-Gorr, KM, Ash, AS, Thwin, SS, Silliman, RA, Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis. J Gen Intern Med 25 (2010), 1045–1050.
Kurtz, ME, Kurtz, JC, Given, CW, Given, B, Predictors of use of health care services among elderly lung cancer patients: the first year after diagnosis. Support Care Cancer 14 (2006), 243–250.
Chesney, TR, Haas, B, Coburn, NG, et al. Immediate and long-term health care support needs of older adults undergoing cancer surgery: a population-based analysis of postoperative homecare utilization. Ann Surg Oncol 28 (2021), 1298–1310.
Jansana, A, Posso, M, Guerrero, I, et al. Health care services use among long-term breast cancer survivors: a systematic review. J Cancer Surviv 13 (2019), 477–493.
Kenzik, KM, Health care use during cancer survivorship: review of 5 years of evidence. Cancer 125 (2019), 673–680.
Souwer, ETD, Verweij, NM, van den Bos, F, et al. Risk stratification for surgical outcomes in older colorectal cancer patients using ISAR-HP and G8 screening tools. J Geriatr Oncol 9 (2018), 110–114.
Chan, WL, Ma, T, Cheung, KL, et al. The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer. J Geriatr Oncol 12 (2021), 557–562.
Lodewijckx, E, Kenis, C, Flamaing, J, et al. Unplanned hospitalizations in older patients with cancer: occurrence and predictive factors. J Geriatr Oncol 12 (2021), 368–374.
Gomes, F, Lorigan, P, Woolley, S, et al. A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients-the ELDERS study. ESMO Open, 6, 2021, 100042.
Bruijnen, CP, Heijmer, A, van Harten-Krouwel, DG, et al. Validation of the G8 screening tool in older patients with cancer considered for surgical treatment. J Geriatr Oncol 12 (2021), 793–798.
Decoster, L, Van Puyvelde, K, Mohile, S, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 26 (2015), 288–300.
Kenzik, KM, Williams, GR, Bhatia, S, Balentine, CJ, Post-acute care among older adults with stage I to III colorectal cancer. J Am Geriatr Soc 67 (2019), 937–944.
Baitar, A, Buntinx, F, De Burghgraeve, T, et al. The utilization of formal and informal home care by older patients with cancer: a Belgian cohort study with two control groups. BMC Health Serv Res, 17, 2017, 644.
Huisman, MG, Ghignone, F, Ugolini, G, et al. Long-term survival and risk of institutionalization in onco-geriatric surgical patients: long-term results of the PREOP study. J Am Geriatr Soc 68 (2020), 1235–1241.
Soto-Perez-de-Celis, E, Aapro, M, Muss, H, ASCO 2020: the geriatric assessment comes of age. Oncologist 25 (2020), 909–912.
Soo, WK, King, MT, Pope, A, Parente, P, Dārziņš, P, Davis, ID, Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial. Lancet Healthy Longev 3 (2022), e617–e627.
Martinez-Tapia, C, Canoui-Poitrine, F, Bastuji-Garin, S, et al. Optimizing the G8 screening tool for older patients with cancer: diagnostic performance and validation of a six-item version. Oncologist 21 (2016), 188–195.
Petit-Monéger, A, Rainfray, M, Soubeyran, P, Bellera, CA, Mathoulin-Pélissier, S, Detection of frailty in elderly cancer patients: improvement of the G8 screening test. J Geriatr Oncol 7 (2016), 99–107.